Best presented numbers so far.
Good financial commentry.
Operational commentry is BS, not substaniated with any number going forward.
Advangen Japan numbers look like BS, load in Maria's costs until they hit breakeven
Margins are very good.
It really comes down to the next two 4C's.
The Lyramid commentry is not Maria's, so that's some relief.
- Forums
- ASX - By Stock
- AN1
- Ann: Appendix 4D and Half Year Report
Ann: Appendix 4D and Half Year Report, page-3
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online